SSO | UBOT | SSO / UBOT | |
Gain YTD | 5.913 | 8.484 | 70% |
Net Assets | 5.67B | 28.7M | 19,770% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 13.00 | 0.00 | - |
Yield | 0.38 | 0.78 | 49% |
Fund Existence | 19 years | 7 years | - |
SSO | UBOT | |
---|---|---|
RSI ODDS (%) | N/A | 3 days ago81% |
Stochastic ODDS (%) | 3 days ago90% | 3 days ago83% |
Momentum ODDS (%) | 3 days ago90% | 3 days ago90% |
MACD ODDS (%) | 3 days ago87% | 3 days ago90% |
TrendWeek ODDS (%) | 3 days ago83% | 3 days ago89% |
TrendMonth ODDS (%) | 3 days ago86% | 3 days ago90% |
Advances ODDS (%) | 26 days ago90% | 26 days ago90% |
Declines ODDS (%) | 5 days ago84% | 5 days ago88% |
BollingerBands ODDS (%) | 3 days ago84% | 3 days ago90% |
Aroon ODDS (%) | 3 days ago83% | 3 days ago88% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 71.75 | 0.83 | +1.17% |
Janus Henderson Global Life Sciences T | |||
GIIYX | 12.03 | N/A | N/A |
GuideStone Funds Intl Eq Idx Instl | |||
RMQCX | 474.70 | N/A | N/A |
Rydex Monthly Rbl NASDAQ-100® 2x Strt C | |||
CCMMX | 9.87 | N/A | N/A |
Conestoga Mid Cap Investors | |||
HLFZX | 8.05 | N/A | N/A |
Harding Loevner Frontier Emerg MktsInstZ |